Benuvia, a Drug Developer Focused on Pharmaceutical Cannabinoids, and the owner of FDA Approved SYNDROS®, Receives Approval from the US DEA to Manufacture Psychedelic Active Pharmaceutical Ingredients including Psilocybin, MDMA and DMT

Benuvia, a Drug Developer Focused on Pharmaceutical Cannabinoids, and the owner of FDA Approved SYNDROS®, Receives Approval from the US DEA to Manufacture Psychedelic Active Pharmaceutical Ingredients including Psilocybin, MDMA and DMT

With this approval, Benuvia has begun focusing on four primary psychedelic ingredients: Psilocybin, N,N-Dimethyl-5-Methoxy-Tryptamine (5-MeO DMT), Dimethyltryptamine (DMT), and 3,4-Methylenedioxymethamphetamine, or MDMA Benuvia will manufacture psychedelic APIs in its...
Job Listings for Week of Jan 4th

Job Listings for Week of Jan 4th

Do you have pharmaceutical and CDMO experience? Do you want to be a part of a growing company? Benuvia Manufacturing is the place for you! We are seeking a variety of positions.  Please click each link to be taken to the job listing and job application instructions:...

Under One Roof

Having all capabilities housed under one roof in our Round Rock facility provides a multitude of benefits for our clients. Clients receive quick response, immediate action and a team approach to product development. Jim Mitchell, Senior Director for API Research &...

Plant Manager Position Available

Benuvia Manufacturing is growing! Seeking a dynamic individual with leadership and motivation skills with an extensive knowledge of Pharma CDMO operations and cGMP. The Plant Manager is a strategic partner within the facility who coordinates production activities with...